DA2 Guidance on the management of Benzodiazepine dependence and withdrawal


Category
Drug and Alcohol
Code
DA2
Issue No
3

Target Audience

Drug & Alcohol Medical Officers / Clinical Practitioners

Purpose

To provide a guideline on the management of people presenting with problems in relation to misuse of benzodiazephines.

Origin

Lead executive
Medical Director

Author and contact number
Clinical Director, Drug & Alcohol Services
0151 604 7309


Policy dates & history

Implementation Date

31 March 2012

Review Date

31 March 2017

Approval Meeting

Medicines Management Group (MMG)

Ratification

Document Quality Group (DQG)

Download

DA2 Guidance on the management of Benzodiazepine Issue 3.pdf

0.26MB
Download Now
Text size A- A+
Contrast options